{
    "nct_id": "NCT02369211",
    "official_title": "Pharmacoeconomics and Related Patient Outcomes of Multi-dose Intravenous Acetaminophen (OFIRMEV) in Patients Undergoing Robotic-assisted Laparoscopic Prostatectomy",
    "criteria": {
        "raw_text": "Inclusion Criteria:\n\n* Patients undergoing robotic-assisted laparoscopic prostatectomy\n* ≥18 years old males\n* American Society of Anesthesiologists class 1-4\n\nExclusion Criteria:\n\n* Chronic opiate use\n* Liver disease (known history of hepatitis B or C, cirrhosis, nonalcoholic steatohepatitis, history of alcoholism, liver function test results greater than 3 times upper limit of normal in the past 3 months)\n* Allergy/hypersensitivity to acetaminophen\n* Patients with baseline dementia\n* Chronic diathesis\n* Chronic kidney disease\n\nhealthyVolunteers: True\n\nsex: MALE\n\nminimumAge: 18 Years\n\nmaximumAge: 85 Years\n\nstdAges: ['ADULT', 'OLDER_ADULT']",
        "inclusion": "* Patients undergoing robotic-assisted laparoscopic prostatectomy\n* ≥18 years old males\n* American Society of Anesthesiologists class 1-4",
        "exclusion": "* Chronic opiate use\n* Liver disease (known history of hepatitis B or C, cirrhosis, nonalcoholic steatohepatitis, history of alcoholism, liver function test results greater than 3 times upper limit of normal in the past 3 months)\n* Allergy/hypersensitivity to acetaminophen\n* Patients with baseline dementia\n* Chronic diathesis\n* Chronic kidney disease"
    }
}